Dario Campana
Fondateur chez Medisix Therapeutics Pte Ltd.
Profil
Dario Campana is the founder of Cogent Biosciences, Inc. (founded in 2014) and Nkarta, Inc. (founded in 2005).
Dr. Campana holds a doctorate degree from the University of Milan and the University of Turin.
Dr. Campana is also the founder of Medisix Therapeutics Pte Ltd.
Postes actifs de Dario Campana
| Sociétés | Poste | Début |
|---|---|---|
Medisix Therapeutics Pte Ltd.
 Medisix Therapeutics Pte Ltd. BiotechnologyHealth Technology Medisix Therapeutics Pte Ltd. operates as an immune engineering company. It develops novel cellular therapies to address T cell malignancies. The firm’s services include CAR-T, oncology, gene and cell therapy. The company was founded by Dario Campana in 2018 and is headquartered in Singapore. | Fondateur | - |
Anciens postes connus de Dario Campana
| Sociétés | Poste | Fin |
|---|---|---|
| NKARTA, INC. | Fondateur | - |
| COGENT BIOSCIENCES, INC. | Fondateur | - |
Formation de Dario Campana
| University of Turin | Doctorate Degree |
| University of Milan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Medisix Therapeutics Pte Ltd.
Medisix Therapeutics Pte Ltd. BiotechnologyHealth Technology Medisix Therapeutics Pte Ltd. operates as an immune engineering company. It develops novel cellular therapies to address T cell malignancies. The firm’s services include CAR-T, oncology, gene and cell therapy. The company was founded by Dario Campana in 2018 and is headquartered in Singapore. | Health Technology |
